GeneDx Holdings Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, filed on June 24, 2024, covers the Annual Meeting of Stockholders held on June 20, 2024. GeneDx Holdings Corp. is a Delaware corporation with its principal executive offices in Stamford, Connecticut. The company's Class A common stock trades on the Nasdaq Stock Market under the symbol "WGS."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
On the record date of April 24, 2024, there were 26,150,866 shares of Class A common stock issued and outstanding. Stockholders approved two proposals at the Annual Meeting:
- Proposal No. 1 (Director Election): Three Class III directors were elected to serve three-year terms expiring in 2027.
- Emily Leproust, Ph.D.: 17,026,055 votes for; 747,294 votes withheld.
- Keith Meister: 17,230,090 votes for; 543,259 votes withheld.
- Richard C. Pfenniger, Jr.: 17,201,550 votes for; 571,799 votes withheld.
- Proposal No. 2 (Auditor Ratification): The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
- Votes For: 23,359,773
- Votes Against: 7,938
- Abstentions: 4,319
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to report the results of the stockholder vote.
Key Facts for Investor Verification
- Verify the full text of the Definitive Proxy Statement on Schedule 14A filed on April 29, 2024, for detailed background on the director nominees and auditor ratification.
- Confirm the total number of shares outstanding (26,150,866) as of the April 24, 2024 record date.
- Note the significant number of broker non-votes (5,598,681) recorded for the director election proposals.
- Review the company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial metrics.